Role of cyclooxygenase 2, p38 and p42/44 MAPK in the secretion of prostacyclin induced by epidermal growth factor, endothelin-1 and angiotensin II in rat ventricular cardiomyocytes
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 35 (1) , 81-89
- https://doi.org/10.1016/s0022-2828(02)00281-x
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31-063799.00, 31-52935.97)
This publication has 27 references indexed in Scilit:
- Epidermal Growth Factor Induces Hypertrophic Responses and Stat5 Activation in Rat Ventricular CardiomyocytesJournal of Molecular and Cellular Cardiology, 2000
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Angiotensin II attenuates renal cortical cyclooxygenase-2 expressionJournal of Clinical Investigation, 1999
- Interleukin-1β Regulation of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Involves the p42/44 and p38 MAPK Signaling Pathways in Cardiac MyocytesHypertension, 1999
- Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase PathwayPublished by Elsevier ,1998
- MAP Kinase Mediates Epidermal Growth Factor- and Phorbol Ester-induced Prostacyclin Formation in CardiomyocytesJournal of Molecular and Cellular Cardiology, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Identification of the Phosphorylation Sites of Cytosolic Phospholipase A2 in Agonist-stimulated Human Platelets and HeLa CellsJournal of Biological Chemistry, 1998
- Cloning and Expression of Cytosolic Phospholipase A2 (cPLA2) and a Naturally Occurring VariantEuropean Journal of Biochemistry, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995